Chemistry Deals
Venture capital investment firm
Why Track Chemistry
Chemistry has 3 deals worth Undisclosed, making them a major investor in the AI industry. They've backed 3 companies.
Total Deals
3
Total Value
Undisclosed
As Investor
3
As Recipient
0
Deals as Investor/Acquirer (3)
Series A funding to expand Meticulous’s AI-driven testing platform that validates AI-generated code changes via simulated user flows and edge cases.
Undisclosed
Jul 15, 2026
View Details →Assort Health raised $120 million in Series C funding led by Menlo Ventures at a $1.2 billion valuation to scale its AI agent platform that automates patient access and administrative workflows for healthcare providers.
Undisclosed
Jun 24, 2026
View Details →Didero raised a $30 million Series A round to expand its agentic AI platform that automates procurement workflows for industrial enterprises.
Undisclosed
Jun 6, 2026
View Details →